We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VNCE:NASDAQVince Holding Corp. Analysis

Data as of 2026-09-02 - not real-time

$6.50

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $6.50, Vince Holding Corp. shows no decisive moving-average alignment, leaving the trend neutral. It has lost 2.8% over the past 30 days. Relative strength is 50.4 — neutral — and the MACD signal is bullish. Recent trading has carved out support near $5.76 and resistance around $8.10.
Multiples put this in undervalued territory at a P/E of 9.8. The average analyst target implies 38.5% above today's level. Revenue is growing at 10.5% on a 3.0% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 92.5%, a beta of 1.83 and a maximum drawdown of 55.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
All three time horizons resolve to buy, carrying 4/10 conviction.

Top Market Events

Seeking Alpha12yApparel IPO Should Provide Investors Who Get Goldman Allocations With A PopApparel Holding Corp VNCE ,...Detailed price information for Vince Holding Corp VNCE-Q from The Globe and Mail including charting and trades.Detailed price information for Vince Holding Corp VNCE-Q from The Globe and Mail including charting and trades.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 4.20
  • MACD momentum is positive
  • 30-day volatility of 92.5%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 4.20
  • Analyst targets imply +38.5% versus the current price
  • 30-day volatility of 92.5%

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • Analyst targets imply +38.5% versus the current price
  • Revenue growth of +10.5%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth10.50%
Profit Margin2.97%
P/E Ratio9.8
ROE21.28%
ROA3.15%
Debt/Equity269.48
P/B Ratio1.7
Op. Cash Flow$5.9M
Free Cash Flow$-3246625

Technical Analysis

TrendNeutral
RSI50.4
Support$5.76
Resistance$8.10
MA 20$6.44
MA 50$6.53
MA 200$4.20
MACDBullish
VolumeIncreasing
Fear & Greed Index92.25

Valuation

Target Price$9.00
Upside/Downside38.46%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.83
Volatility92.51%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.